XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Capital in excess of par value
Retained earnings
Retained earnings
Revision of Prior Period, Accounting Standards Update, Adjustment
Accumulated foreign currency adjustment attributable to parent
Accumulated defined benefit plans adjustment attributable to parent
Accumulated other comprehensive (loss) income
Treasury stock
Balance at the beginning of the year at Dec. 31, 2019   $ 2,662 $ 832,821 $ 6,387,612 $ (360) $ (286,248) $ (246,891)   $ (1,574,464)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued   9              
Issuance of common stock under employee stock plans     27,886           8,638
Share-based compensation expense     29,878            
Net income $ 651,414     651,414          
Cash dividends paid       (123,690)          
Stockholders' Equity, Other       0          
Translation adjustments           (2,103)      
Change in long-term intercompany notes           7,979      
Net investment hedge instruments gain (loss), net of tax of $(5,715) and $10,459 for the quarter ended September 30, 2021 and 2020, and $(10,194) and $3,681 for the nine months ended September 30, 2021 and 2020, respectively           (11,431)      
Amortization of net actuarial loss and other, net of tax of $(527) and $(531) for the quarter ended September 30, 2021 and 2020, and $(1,581) and $(1,593) for the nine months ended September 30, 2021 and 2020, respectively             5,049    
Purchase of treasury stock                 (4,569)
Balance at the end of the year at Sep. 30, 2020 5,704,192 2,671 890,585 6,914,976   (291,803) (241,842) $ (533,645) (1,570,395)
Balance at the beginning of the year at Jun. 30, 2020   2,668 860,771 6,751,686   (315,252) (243,525)   (1,569,908)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued   3              
Issuance of common stock under employee stock plans     18,989           (414)
Share-based compensation expense     10,825            
Net income 204,581     204,581          
Cash dividends paid       (41,291)          
Stockholders' Equity, Other       0          
Translation adjustments           46,922      
Change in long-term intercompany notes           9,003      
Net investment hedge instruments gain (loss), net of tax of $(5,715) and $10,459 for the quarter ended September 30, 2021 and 2020, and $(10,194) and $3,681 for the nine months ended September 30, 2021 and 2020, respectively           (32,476)      
Amortization of net actuarial loss and other, net of tax of $(527) and $(531) for the quarter ended September 30, 2021 and 2020, and $(1,581) and $(1,593) for the nine months ended September 30, 2021 and 2020, respectively             1,683    
Purchase of treasury stock                 (73)
Balance at the end of the year at Sep. 30, 2020 5,704,192 2,671 890,585 6,914,976   (291,803) (241,842) (533,645) (1,570,395)
Balance at the beginning of the year at Dec. 31, 2020 5,949,346 2,676 921,752 7,094,656   (250,748) (253,720)   (1,565,270)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued   10              
Issuance of common stock under employee stock plans     29,544           7,309
Share-based compensation expense     35,021            
Net income 708,372     708,372          
Cash dividends paid       (138,345)          
Stockholders' Equity, Other       (1)          
Translation adjustments           (45,160)      
Change in long-term intercompany notes           (11,041)      
Net investment hedge instruments gain (loss), net of tax of $(5,715) and $10,459 for the quarter ended September 30, 2021 and 2020, and $(10,194) and $3,681 for the nine months ended September 30, 2021 and 2020, respectively           31,514      
Amortization of net actuarial loss and other, net of tax of $(527) and $(531) for the quarter ended September 30, 2021 and 2020, and $(1,581) and $(1,593) for the nine months ended September 30, 2021 and 2020, respectively             4,890    
Purchase of treasury stock                 (13,063)
Balance at the end of the year at Sep. 30, 2021 6,558,396 2,686 986,317 7,664,682   (275,435) (248,830) (524,265) (1,571,024)
Balance at the beginning of the year at Jun. 30, 2021   2,684 964,791 7,453,401   (256,421) (250,460)   (1,570,696)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued   2              
Issuance of common stock under employee stock plans     10,098           (143)
Share-based compensation expense     11,428            
Net income 257,460     257,460          
Cash dividends paid       (46,178)          
Stockholders' Equity, Other       (1)          
Translation adjustments           (31,207)      
Change in long-term intercompany notes           (5,475)      
Net investment hedge instruments gain (loss), net of tax of $(5,715) and $10,459 for the quarter ended September 30, 2021 and 2020, and $(10,194) and $3,681 for the nine months ended September 30, 2021 and 2020, respectively           17,668      
Amortization of net actuarial loss and other, net of tax of $(527) and $(531) for the quarter ended September 30, 2021 and 2020, and $(1,581) and $(1,593) for the nine months ended September 30, 2021 and 2020, respectively             1,630    
Purchase of treasury stock                 (185)
Balance at the end of the year at Sep. 30, 2021 $ 6,558,396 $ 2,686 $ 986,317 $ 7,664,682   $ (275,435) $ (248,830) $ (524,265) $ (1,571,024)